In DCCT, C-peptide responders (C-peptide response above 0.2 nmol/l) had significantly lower rates of albumin excretion (P = 0.027) and nearly significantly lower prevalence of retinopathy (P = 0.057) than non-responders, after adjusting for age and sex (12, 15). This evidence concerns the gene ALB and retinal disorder.